2017-03-23,Arbutus Announces Appointment Of Daniel Burgess To Board Of Directors
2017-03-21,Arbutus Announces Year-End 2016 Financial Results
2017-03-16,Arbutus Licenses LNP Delivery Technology To Alexion For Use In Single Messenger RNA Product Candidate
2017-03-06,Arbutus To Participate In Upcoming Investor Conferences
2017-02-09,Arbutus To Participate In Upcoming Investor Conferences
2017-02-08,Arbutus Is Granted A Pre-trial Injunction Restraining Acuitas From Entering Into Agreements Sublicensing Arbutus LNP Technology
2016-12-12,Arbutus Provides Additional Data From The ARB-1467 Phase II Clinical Trial In HBV Patients
2016-11-14,Arbutus Presents HBV Drug Combination Studies At AASLD
2016-11-03,Arbutus Provides Corporate Update And Announces Third Quarter 2016 Financial Results
2016-10-19,Patrick Machado Joins Board Of Directors Of Roivant Sciences
2016-10-03,Arbutus Recognizes Liver Cancer Awareness Month With Grant To Support The Hepatitis B Foundation's Patient Storytelling Campaign
2016-10-01,Arbutus To Present HBV Data At The 2016 AASLD Liver Meeting
2016-09-29,Arbutus Reports Interim Multi-Dose Results From Phase II Clinical Trial Of ARB-1467 In Patients With Chronic HBV Infection
2016-09-13,Arbutus' Chief Scientific Officer, Dr. Michael J. Sofia, Awarded The 2016 Lasker~DeBakey Clinical Medical Research Award
2016-08-10,Arbutus To Present At The 2016 Wedbush PacGrow Healthcare Conference
2016-08-08,Arbutus Announces Issuance Of Broad New US Patent For LNP Delivery Technology
2016-08-04,Arbutus Provides Corporate Update And Announces Second Quarter 2016 Financial Results
2016-07-19,Arbutus Reports Topline Results From TKM-PLK1 HCC Clinical Trial
2016-07-18,Arbutus To Present Data On New LNP Formulations For Delivery Of MRNA At The 2016 Controlled Release Society Conference
2016-07-13,Roivant Sciences Appoints Professor Andrew Lo, PhD As Independent Director
2016-06-30,Arbutus To Present MRNA Delivery Data At The 32nd Annual Meeting Of The Japan Society Of Drug Delivery System
2016-06-03,Arbutus To Participate In Upcoming Investor Conferences
2016-06-01,Arbutus To Present At The 5th Antiviral Drugs Research And Development Conference
2016-05-04,Arbutus Provides Corporate Update And Announces First Quarter 2016 Financial Results
2016-05-03,Arbutus Expands HBV Pipeline
2016-04-29,Arbutus To Provide A Corporate Update And Release First Quarter 2016 Financial Results
2016-04-27,Arbutus To Participate In Upcoming Investor Conferences
2016-04-22,Arbutus Presents Data From Combination Activity Studies Of HBV Drug Candidates
2016-04-21,Arbutus Announces Planned Executive Departure
2016-04-14,Arbutus Presents Data On HBV Capsid Assembly Inhibitor AB-423 At EASL 2016
2016-03-30,Arbutus To Present Preclinical HBV Data At EASL 2016
2016-03-09,Arbutus Announces Year-End 2015 Financial Results
2016-03-08,Arbutus Appoints Dr. Elizabeth Howard Executive Vice President And General Counsel
2016-03-03,Arbutus Biopharma To Participate In Upcoming Investor Conferences
2016-02-04,Arbutus Biopharma To Participate In Upcoming Investor Conferences
2016-01-20,Kuros Biosurgery Holding Ltd. Closes Merger With Cytos Biotechnology Ltd. Which Is Renamed Kuros Biosciences Ltd.
2016-01-10,Arbutus Provides A Corporate Update And Outlines 2016 Milestones
2015-11-05,Arbutus Biopharma Announces Third Quarter 2015 Financial Results
2015-10-28,Arbutus Provides An HBV Pipeline Update
2015-10-15,Dr. Michael J. Sofia, Arbutus' Chief Scientific Officer, Named Economist's 2015 Innovation Award Winner In The Bioscience Category
2015-10-06,Arbutus Biopharma Presents Preclinical Data At The 2015 International Meeting On Molecular Biology Of Hepatitis B Viruses
2015-10-01,Arbutus To Present TKM-HBV Data At The 2015 AASLD Liver Meeting
2015-09-09,Arbutus To Present At The Baird 2015 Healthcare Conference
2015-09-09,Arbutus Biopharma Enters Oversold Territory (ABUS)
2015-09-03,5 Stocks Under $10 Set to Soar
2015-08-25,Arbutus Announces Initiation Of Patient Dosing In The TKM-PLK1 HCC Expansion Cohort
2015-08-07,Arbutus To Present At 2015 Wedbush PacGrow Healthcare Conference
2015-08-06,Arbutus Biopharma Is Now Oversold (ABUS)
2015-08-05,Arbutus Biopharma Announces Second Quarter 2015 Financial Results
,
,
,
,
